Johnson & Johnson Ordered to Pay $344 Million for Deceptively Marketing Pelvic Mesh ProductThe Motley Fool • 01/31/20
Johnson & Johnson's Nasal Spray Rejected in England Over Cost EffectivenessThe Motley Fool • 01/28/20
Johnson & Johnson Is 'Confident' In Ability To Treat Coronavirus, But Vaccine Could Take TimeBenzinga • 01/27/20
J&J scientific officer 'pretty confident' they can create coronavirus vaccine as outbreak widensCNBC • 01/27/20
Johnson & Johnson's $8bn Fine Gets Thrown Out, And Other News: The Good, Bad, And Ugly Of BiopharmaSeeking Alpha • 01/23/20
Johnson & Johnson (JNJ) CEO Alex Gorsky on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 01/22/20
Johnson & Johnson's Fourth-Quarter Results Leave Wall Street With Mixed EmotionsThe Motley Fool • 01/22/20